Nomadogen is a medical biotechnology company founded by four graduate student members of the award-winning University of Lethbridge 2014 International Genetically Engineered Machines (iGEM) team.


Nomadogen's patented technology is a combination genetic and cellular therapy dubbed "Nomadocytes", which utilizes patient-derived cells to non-invasively deliver therapeutic molecules to brain cells affected by stroke, traumatic brain injury, and neurodegenerative disease. Nomadocytes are currently in preclinical trials.



Lethbridge, Alberta, Canada

© 2018 Nomadogen Biotechnologies Inc.

This site was designed with the
website builder. Create your website today.
Start Now